Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Other Non-Current Assets (2024 - 2025)

Historic Other Non-Current Assets for Prelude Therapeutics (PRLD) over the last 2 years, with Q3 2025 value amounting to $3.2 million.

  • Prelude Therapeutics' Other Non-Current Assets fell 2000.49% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 2000.49%. This contributed to the annual value of $4.0 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Prelude Therapeutics reported Other Non-Current Assets of $3.2 million as of Q3 2025, which was down 2000.49% from $4.0 million recorded in Q2 2025.
  • Prelude Therapeutics' 5-year Other Non-Current Assets high stood at $4.0 million for Q1 2024, and its period low was $3.2 million during Q3 2025.